Effects of mechanical vibration generated on a vibratory platform in patients with Chronic Obstructive Pulmonary Disease
- Conditions
- Chronic obstructive pulmonary diseaseC08.381.495.389
- Registration Number
- RBR-72dqtm
- Lead Sponsor
- niversidade do Estado do Rio de Janeiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients of both sexes, under follow-up at Serviço de Pneumologia do HUPE, diagnosed with COPD based on the criteria established by GOLD; patients with stable disease; with Forced Expiratory Volume in the 1st Second less than 50%; independent patients; signed by the Free and Informed Consent Form.
Patients with exacerbation for less than 3 months; patients with labyrinthitis; patients with osteoporosis reported; patients with other respiratory diseases; patients using pacemaker; patients with previous history of fractures or other orthopedic diseases submitted to surgeries with implantation of metallic material; patients with peripheral vascular disease or thromboembolism; patients smoker or severe alcoholic; patients with decompensated cardiovascular disease; patients with aneurysm; patients with previous vitreous hemorrhage; patients in malnutrition; postoperative patients; patients with neurological disease that causes fear of movements on the vibrating platform; severe or incapacitating clinical illness, at the discretion of the investigator.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effects of WBVE on the electromyographic tracing of the vastus lateralis, vastus medialis and rectus femoris, through surface electromyography in individuals with COPD;To evaluate the effects of WBVE on blood pressure, heart rate, respiratory rate and oxygen saturation through pulse oximetry in individuals with COPD;To evaluate the effects of WBVE on dyspnea, through the Modified Scale of BORG and Medical Research Council (MRC) in individuals with COPD
- Secondary Outcome Measures
Name Time Method